Generic drugmaker Sandoz files anti-dumping complaint about Chinese antibiotics imports

29/05/2026 05:06 - 25 Views

Swiss generic drugmaker Sandoz (SDZ.S), opens new tab filed a draft anti-dumping complaint with the European Commission ‌over Chinese imports of the antibiotic ingredient amoxicillin, part of the penicillin family, the company said on Thursday.

Sandoz says it has the ⁠only major remaining vertically integrated production network for penicillins in Europe.

Sandoz says Chinese market-distorting behaviours include sustained below-cost pricing, state subsidies and concentration of global capacity in China.

Chief Executive Richard Saynor said Europe risks losing ‌antibiotic ⁠manufacturing capacity, saying that up to 90% of global antibiotic active ingredients are now produced outside Europe.

"Safeguarding antibiotic supply ⁠is not only a health policy issue, but a question of economic security and ⁠strategic trade policy. Europe must act now to safeguard independent ⁠supply in years to come," Saynor said in the statement.

Source: Reuters